Novartis AG
Change company Symbol lookup
Select an option...
NVS Novartis AG
UBER Uber Technologies Inc
LMT Lockheed Martin Corp
SHLX Shell Midstream Partners LP
SEDG Solaredge Technologies Inc
LUNA Luna Innovations Inc
PAAS Pan American Silver Corp
FSD First Trust High Inc Long/Short Fund
GDV Gabelli Dividend & Income Trust
MNSB MainStreet Bancshares Inc
Go

Health Care : Pharmaceuticals | Large Cap Blend
Based in Switzerland
Company profile

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$80.70
Day's Change
-1.21 (-1.48%)
Bid
--
Ask
--
B/A Size
--
Day's High
81.23
Day's Low
80.53
Volume
(Below Average)
Volume:
1,730,333

10-day average volume:
2,011,874
1,730,333

MedMen Announces Grand Opening of Orlando, Florida, Dispensary

8:00 am ET September 9, 2021 (BusinessWire) Print

MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across the nation, today announced the opening of its newest store location in Orlando, Florida. MedMen Orlando will occupy 5,500 square feet of prime retail territory on 11551 University Boulevard and serve as a key focal point of the Company's operations in the vibrant and burgeoning Central Florida area. This latest opening brings MedMen's national store count to 27, including 6 locations in Florida, and demonstrates the Company's commitment to rapid growth and new store openings.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210909005252/en/

"Florida continues to be one of our most exciting areas for growth," said Tom Lynch, CEO, MedMen. "Not only is the patient population growing in the country's third largest state, but we believe the patients of Florida can be better served with our differentiated MedMen products. We hold quality and safety above all else, are growing our assortment and tailoring everything - from our potency to our parking spaces - to what Florida patients need and deserve."

Staffed by graduates of MedMen's robust employee training program, MedMen Orlando will carry a full inventory of vaporizers, concentrates, pre-rolls, topicals and flower, including an array of high cannabinoid and terpene offerings and a diverse selection of brands such as MedMen Red, Luxlyte and the award-winning Mary's Medicinals. These premium products will be available in-store or through in-store pickup orders placed in advance via phone or MedMen's proprietary online ordering service for patients and Buds rewards members.

Florida has a rich cannabis history and is home to one of the world's most knowledgeable medical marijuana patient populations. The city of Orlando is arguably one of the world's most highly sought after tourist destinations, welcoming approximately 60 million tourists annually.

Continued Lynch, "The Florida market is one of MedMen's most exciting levers for expansion as we continue to execute against a disciplined growth plan to create the industry's premier retail experience. As one of the most recognizable names in cannabis, we're committed to serving Floridians with best-in-class service, brands and an inimitable shopping experience, as well as a deep understanding, appreciation and respect for the medicine we are providing to thousands of patients."

To purchase MedMen products, please visit www.medmen.com, or find a dispensary near you at https://www.medmen.com/stores.

ABOUT MEDMEN:

MedMen is North America's leading cannabis retailer with flagship locations in Los Angeles, Las Vegas, Miami, Chicago, and New York. MedMen offers a robust selection of high-quality products, including MedMen-owned brands LuxLyte, and MedMen Red through its premium retail stores, as well as in-store pick up. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. Learn more about MedMen at www.medmen.com.

Source: MedMen Enterprises

View source version on businesswire.com: https://www.businesswire.com/news/home/20210909005252/en/

SOURCE: MedMen Enterprises

MEDIA CONTACT:
Lisa Weser
Email: MedMen@Trailblaze.co

INVESTOR RELATIONS CONTACT:
Morry Brown
Email: investors@MedMen.com

 
comtex tracking

COMTEX_393046508/1006/2021-09-09T08:00:06

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.